ATC Group: J07BF03 Poliomyelitis, trivalent, inactivated, whole virus

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of J07BF03 in the ATC hierarchy

Level Code Title
1 J Antiinfectives for systemic use
2 J07 Vaccines
3 J07B Viral vaccines
4 J07BF Poliomyelitis vaccines
5 J07BF03 Poliomyelitis, trivalent, inactivated, whole virus

Medicines in this ATC group

United States (US)

  • (combination) IPOL

Austria (AT)

Canada (CA)

Croatia (HR)

Estonia (EE)

Finland (FI)

France (FR)

Hong Kong (HK)

Israel (IL)

Japan (JP)

Lithuania (LT)

Malta (MT)

New Zealand (NZ)

  • (combination) IPOL

Poland (PL)

Singapore (SG)

South Africa (ZA)

Tunisia (TN)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.